Cihan University–Erbil Assistant Lecturer Explores Advanced Molecular Diagnostic Technologies at Ustar Biotechnologies in China
As part of the international training program entitled ‘Capacity Building for Primary Healthcare Services in Developing Countries,’ Assistant Lecturer Hero Ismael Mohammed from the Biomedical Sciences Department at Cihan University–Erbil participated in a field visit to Ustar Biotechnologies Ltd. in Hangzhou City, Zhejiang Province, China. The visit provided an opportunity to observe advanced digital molecular diagnostic technologies and innovative solutions for the rapid detection of infectious diseases.
The participants from various countries were warmly received by Mr. Lin Kevin, Chief Executive Officer of Ustar Biotechnologies and the inventor of the MultNAT molecular diagnostic device. During the welcoming session, Mr. Lin introduced the company’s vision of advancing point-of-care molecular diagnostics through innovative technologies that enhance the speed, accessibility, and accuracy of disease detection in healthcare settings.
During a technical presentation held in the company’s conference room, Ms. Nora Wang, Head of International Sales, delivered a comprehensive overview of the MultNAT system. She explained that the platform is an automated real-time polymerase chain reaction (real-time PCR) molecular diagnostic system designed for the rapid detection of a wide range of infectious diseases. Compared with conventional real-time PCR workflows, the system significantly reduces testing time and operational costs while maintaining high analytical performance, making it particularly suitable for hospitals, clinical laboratories, emergency testing, and resource-limited healthcare settings.
Following the presentation, Mr. Lin personally guided the participants on a tour of the company’s manufacturing facilities. Assistant Lecturer Hero Ismael Mohammed observed the production process for diagnostic reagents, including buffer and solution preparation, automated filling operations, packaging procedures, and the quality monitoring systems implemented throughout the manufacturing process. The visit provided valuable insights into the company’s rigorous quality assurance standards, advanced manufacturing automation, and regulatory compliance practices, highlighting its commitment to producing reliable, high-quality molecular diagnostic products for healthcare systems worldwide.
